Amedisys Cash And Short Term Investments from 2010 to 2024

AMED Stock  USD 91.23  0.21  0.23%   
Amedisys' Cash And Short Term Investments are increasing over the years with slightly volatile fluctuation. Overall, Cash And Short Term Investments are expected to go to about 132.8 M this year. Cash And Short Term Investments is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. View All Fundamentals
 
Cash And Short Term Investments  
First Reported
1993-12-31
Previous Quarter
157.4 M
Current Value
245.4 M
Quarterly Volatility
47.6 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Amedisys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amedisys' main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.6 M, Interest Expense of 32.8 M or Selling General Administrative of 333.3 M, as well as many indicators such as Price To Sales Ratio of 0.86, Dividend Yield of 3.0E-4 or PTB Ratio of 2.57. Amedisys financial statements analysis is a perfect complement when working with Amedisys Valuation or Volatility modules.
  
Check out the analysis of Amedisys Correlation against competitors.
For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.

Latest Amedisys' Cash And Short Term Investments Growth Pattern

Below is the plot of the Cash And Short Term Investments of Amedisys over the last few years. Short Term Investments is an account in the current assets section of Amedisys balance sheet. This account contains Amedisys investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Amedisys fairly quickly. It is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. Amedisys' Cash And Short Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amedisys' overall financial position and show how it may be relating to other accounts over time.
Cash And Short Term Investments10 Years Trend
Slightly volatile
   Cash And Short Term Investments   
       Timeline  

Amedisys Cash And Short Term Investments Regression Statistics

Arithmetic Mean47,188,900
Geometric Mean29,500,267
Coefficient Of Variation87.21
Mean Deviation31,927,067
Median30,294,000
Standard Deviation41,152,900
Sample Variance1693.6T
Range131.7M
R-Value0.71
Mean Square Error892.8T
R-Squared0.51
Significance0
Slope6,574,523
Total Sum of Squares23709.9T

Amedisys Cash And Short Term Investments History

2024132.8 M
2023126.5 M
202240.5 M
202142.7 M
202081.8 M
201930.3 M
201820.2 M

About Amedisys Financial Statements

Amedisys stakeholders use historical fundamental indicators, such as Amedisys' Cash And Short Term Investments, to determine how well the company is positioned to perform in the future. Although Amedisys investors may analyze each financial statement separately, they are all interrelated. For example, changes in Amedisys' assets and liabilities are reflected in the revenues and expenses on Amedisys' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Amedisys. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash And Short Term Investments126.5 M132.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Amedisys is a strong investment it is important to analyze Amedisys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amedisys' future performance. For an informed investment choice regarding Amedisys Stock, refer to the following important reports:
Check out the analysis of Amedisys Correlation against competitors.
For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.35)
Earnings Share
2.52
Revenue Per Share
71.004
Quarterly Revenue Growth
0.057
Return On Assets
0.0627
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.